Absci Corporation
NASDAQ: ABSI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sean McClain
- Employees
- 156
- Headquarters
- Vancouver, United States
- IPO year
- 2021
- Market cap
- $1.6B
- Website
- https://www.absci.com
Loading ABSI…
Loading profile data…Frequently asked questions about ABSI
What does Absci Corporation (ABSI) do?
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, p...
Where does ABSI trade?
Absci Corporation (ABSI) trades on the NASDAQ Global Select.
What sector is ABSI in?
Absci Corporation (ABSI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Absci Corporation?
Sean McClain is the chief executive officer of Absci Corporation (ABSI).
Where is Absci Corporation headquartered?
Absci Corporation is headquartered in United States.
Does ABSI pay a dividend?
Absci Corporation (ABSI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABSI go public?
Absci Corporation (ABSI) completed its initial public offering in 2021.